Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$23.78
-0.9%
$25.48
$21.33
$40.49
$12.32B0.65.98 million shs7.04 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$185.90
-0.5%
$186.72
$163.33
$251.99
$53.55B0.271.67 million shs1.32 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$76.10
-1.9%
$78.91
$64.00
$83.00
$45.54B1.073.78 million shs3.73 million shs
ResMed Inc. stock logo
RMD
ResMed
$271.39
+0.5%
$274.65
$199.92
$293.81
$39.55B0.85937,685 shs940,941 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-0.92%-1.23%-1.74%-20.52%-40.13%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.71%-2.92%-5.09%+9.35%-20.61%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
-1.81%-5.21%-2.76%+3.81%+11.06%
ResMed Inc. stock logo
RMD
ResMed
+0.27%-2.86%-4.72%+8.50%+9.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$23.78
-0.9%
$25.48
$21.33
$40.49
$12.32B0.65.98 million shs7.04 million shs
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$185.90
-0.5%
$186.72
$163.33
$251.99
$53.55B0.271.67 million shs1.32 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$76.10
-1.9%
$78.91
$64.00
$83.00
$45.54B1.073.78 million shs3.73 million shs
ResMed Inc. stock logo
RMD
ResMed
$271.39
+0.5%
$274.65
$199.92
$293.81
$39.55B0.85937,685 shs940,941 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-0.92%-1.23%-1.74%-20.52%-40.13%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.71%-2.92%-5.09%+9.35%-20.61%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
-1.81%-5.21%-2.76%+3.81%+11.06%
ResMed Inc. stock logo
RMD
ResMed
+0.27%-2.86%-4.72%+8.50%+9.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.20
Hold$30.1126.62% Upside
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.36
Hold$211.4413.74% Upside
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.67
Moderate Buy$86.2613.36% Upside
ResMed Inc. stock logo
RMD
ResMed
2.82
Moderate Buy$278.362.57% Upside

Current Analyst Ratings Breakdown

Latest BAX, BDX, EW, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2025
ResMed Inc. stock logo
RMD
ResMed
CLSA
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldOutperform
8/11/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$196.00 ➝ $197.00
8/8/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$172.00 ➝ $184.00
8/8/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$185.00 ➝ $200.00
8/7/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$84.00 ➝ $88.00
8/4/2025
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$41.00 ➝ $36.00
8/4/2025
Baxter International Inc. stock logo
BAX
Baxter International
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$35.00 ➝ $24.00
8/4/2025
Baxter International Inc. stock logo
BAX
Baxter International
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyHold$36.00 ➝ $25.00
8/1/2025
Baxter International Inc. stock logo
BAX
Baxter International
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$33.00 ➝ $24.00
8/1/2025
Baxter International Inc. stock logo
BAX
Baxter International
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyNeutral$25.00
8/1/2025
ResMed Inc. stock logo
RMD
ResMed
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.64B1.15$4.71 per share5.05$13.76 per share1.73
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.18B2.64$21.03 per share8.84$89.57 per share2.08
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$5.44B8.21$2.68 per share28.41$17.06 per share4.46
ResMed Inc. stock logo
RMD
ResMed
$5.15B7.72$11.26 per share24.11$40.70 per share6.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$0.30N/A8.710.78-1.42%16.96%5.24%11/14/2025 (Estimated)
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$5.5633.4411.891.517.51%16.23%7.46%11/6/2025 (Estimated)
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$4.17B$6.9510.9527.673.7472.96%15.01%11.56%10/23/2025 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.40B$9.5128.5426.201.8027.22%25.62%18.69%10/23/2025 (Estimated)

Latest BAX, BDX, EW, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q3 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.40$3.68+$0.28$1.99$5.50 billion$5.51 billion
7/31/2025Q2 2025
Baxter International Inc. stock logo
BAX
Baxter International
$0.60$0.59-$0.01$0.18$2.82 billion$2.81 billion
7/31/2025Q4 2025
ResMed Inc. stock logo
RMD
ResMed
$2.47$2.55+$0.08$2.58$1.33 billion$1.35 billion
7/24/2025Q2 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.62$0.67+$0.05$0.56$1.49 billion$1.53 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.682.86%N/AN/A N/A
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.24%N/A74.82%53 Years
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.400.88%N/A25.24%13 Years

Latest BAX, BDX, EW, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/14/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.75%8/29/20258/29/202510/1/2025
7/22/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.042.17%9/8/20259/8/20259/30/2025
7/31/2025
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.600.88%8/14/20258/14/20259/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.30
2.30
1.49
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.69
1.10
0.62
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.68
3.87
ResMed Inc. stock logo
RMD
ResMed
0.11
3.44
2.53

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.20%
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.36%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.34%
ResMed Inc. stock logo
RMD
ResMed
0.71%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
38,000513.62 million512.59 millionOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000286.63 million285.60 millionOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
15,800587.10 million585.10 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,600146.41 million145.38 millionOptionable

Recent News About These Companies

Swedbank AB Purchases 324,428 Shares of ResMed Inc. $RMD
Inspire Investing LLC Boosts Holdings in ResMed Inc. $RMD
MBB Public Markets I LLC Invests $302,000 in ResMed Inc. $RMD
WBI Investments LLC Trims Position in ResMed Inc. $RMD
Goldman Sachs Group Inc. Grows Stock Position in ResMed Inc. $RMD
ResMed (NYSE:RMD) Shares Down 4.7% - Time to Sell?
Here's Why ResMed (RMD) is a Strong Growth Stock
ImmuCell (NASDAQ:ICCC) & ResMed (NYSE:RMD) Critical Comparison
Alliancebernstein L.P. Cuts Position in ResMed Inc. $RMD

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baxter International stock logo

Baxter International NYSE:BAX

$23.78 -0.21 (-0.88%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$23.88 +0.09 (+0.40%)
As of 09/15/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$185.90 -0.94 (-0.50%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$184.86 -1.05 (-0.56%)
As of 09/15/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$76.10 -1.47 (-1.90%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$75.76 -0.34 (-0.45%)
As of 09/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

ResMed stock logo

ResMed NYSE:RMD

$271.39 +1.25 (+0.46%)
Closing price 09/15/2025 03:59 PM Eastern
Extended Trading
$278.00 +6.61 (+2.44%)
As of 09/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.